patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Time-Line on Phase I, Took app 13 months

Phase II will utilize the 3D cells from our bioreactior, so upon this first output Phase II may begin, I believe it's been found that this won't happen till the ladder end of 2012.

''With the completion of the scaling up process, Pluristem will be positioned in becoming the leading manufacturer of cells for a variety of product candidates.''

http://www.pluristem.com/index.php?option=com_content&view=article&id=209:-april-6&catid=4&Itemid=104

grrrrrr

e

Share
New Message
Please login to post a reply